Evidence map›Paper›PMID 25383714›Full record

ArticlePloS one2014

A physiologically-motivated compartment-based model of the effect of inhaled hypertonic saline on mucociliary clearance and liquid transport in cystic fibrosis.

Matthew R Markovetz, Timothy E Corcoran, Landon W Locke, Michael M Myerburg, Joseph M Pilewski, Robert S Parker

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. A review of inflammatory mechanism in airway diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Matthew R MarkovetzDepartment of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, United States of America.
Timothy E CorcoranDepartment of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, United States of America; Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, United States of America.
Landon W LockePulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Michael M MyerburgPulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Joseph M PilewskiPulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America.
Robert S ParkerDepartment of Chemical and Petroleum Engineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA, United States of America; McGowan Institute of Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America; Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Laboratories, University of Pittsburgh, Pittsburgh, PA, United States of America; University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA, United States of America.
University of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Translational StudiesP30DK072506 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ALCORN, JOHN F · 2005 to 2017
$12.5M
Translational Training Program in Pulmonary Biology and MedicineT32HL007563 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Melanie Koenigshoff · 1985 to 2026
$12.3M
Imaging Airway Liquid Absorption in Cystic FibrosisR01HL108929 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CORCORAN, TIMOTHY E · 2011 to 2015
$1.9M
Th2 inflammation promotes airway surface liquid dehydrationR01HL112863 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MYERBURG, MICHAEL M · 2012 to 2016
$1.9M
Building Multilevel Models of Therapeutic Response in the LungsU01HL131046 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CORCORAN, TIMOTHY E, PARKER, ROBERT S. · 2016 to 2019
$1.7M
NCATS NIH HHS UL1 TR000005NHLBI NIH HHS R01 HL108929NHLBI NIH HHS R01HL108929NHLBI NIH HHS R01HL112862NHLBI NIH HHS R01 HL112863NHLBI NIH HHS T32 HL007563NHLBI NIH HHS U01 HL131046NIDDK NIH HHS P30 DK072506NIDDK NIH HHS P30DK072506
6 · The paper itself

Abstract

backgroundCystic Fibrosis (CF) lung disease is characterized by liquid hyperabsorption, airway surface dehydration, and impaired mucociliary clearance (MCC). Herein, we present a compartment-based mathematical model of the airway that extends the resolution of functional imaging data.

methodsUsing functional imaging data to inform our model, we developed a system of mechanism-motivated ordinary differential equations to describe the mucociliary clearance and absorption of aerosolized radiolabeled particle and small molecules probes from human subjects with and without CF. We also utilized a novel imaging metric in vitro to gauge the fraction of airway epithelial cells that have functional ciliary activity.

resultsThis model, and its incorporated kinetic rate parameters, captures the MCC and liquid dynamics of the hyperabsorptive state in CF airways and the mitigation of that state by hypertonic saline treatment.

conclusionsWe postulate, based on the model structure and its ability to capture clinical patient data, that patients with CF have regions of airway with diminished MCC function that can be recruited with hypertonic saline treatment. In so doing, this model structure not only makes a case for durable osmotic agents used in lung-region specific treatments, but also may provide a possible clinical endpoint, the fraction of functional ciliated airway.

Indexed as

HydrodynamicsModels, BiologicalAdministration, InhalationBiological TransportCystic FibrosisHumansMucociliary ClearanceSaline Solution, HypertonicSaline Solution, Hypertonic

Identifiers

PMID25383714
PMCPMC4226497
OpenAlexW2055229586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.